Slater Paula G, Yarur Hector E, Gysling Katia
Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile
Mol Pharmacol. 2016 Nov;90(5):627-632. doi: 10.1124/mol.116.104927. Epub 2016 Sep 9.
The corticotropin-releasing factor (CRF) system, which is involved in stress, addiction, and anxiety disorders such as depression, acts through G-protein-coupled receptors (GPCRs) known as type-1 and type-2 CRF receptors. The purpose of this review is to highlight recent advances in the interactions of CRF receptors with other GPCRs and non-GPCR proteins and their associated functional consequences. A better understanding of these interactions may generate new pharmacological alternatives for the treatment of addiction and stress-related disorders.
促肾上腺皮质激素释放因子(CRF)系统参与应激、成瘾以及诸如抑郁症等焦虑症,它通过被称为1型和2型CRF受体的G蛋白偶联受体(GPCR)发挥作用。本综述的目的是强调CRF受体与其他GPCR和非GPCR蛋白相互作用的最新进展及其相关的功能后果。更好地理解这些相互作用可能会为成瘾和应激相关疾病的治疗带来新的药理学选择。